Production (Stage)
CardioComm Solutions, Inc.
EKG.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -40.95% | -43.90% | -23.18% | -22.79% | -15.47% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -40.95% | -43.90% | -23.18% | -22.79% | -15.47% |
| Cost of Revenue | -85.61% | -86.92% | -83.39% | -82.60% | -51.31% |
| Gross Profit | -33.35% | -29.79% | 0.84% | -0.20% | -3.33% |
| SG&A Expenses | -19.25% | 2.76% | 19.49% | 17.33% | 13.03% |
| Depreciation & Amortization | 16.57% | -5.37% | -14.02% | -20.54% | -17.73% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -26.72% | -17.91% | -6.46% | -8.99% | -3.81% |
| Operating Income | -62.73% | -290.78% | -88.61% | -150.25% | -627.46% |
| Income Before Tax | -95.54% | -173.27% | -30.03% | -41.08% | -3,363.64% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -95.54% | -173.27% | -30.03% | -41.08% | -3,363.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -95.54% | -173.27% | -30.03% | -41.08% | -3,363.64% |
| EBIT | -62.73% | -290.78% | -88.61% | -150.25% | -627.46% |
| EBITDA | -67.41% | -322.68% | -97.00% | -175.05% | -1,079.76% |
| EPS Basic | -75.00% | -166.67% | -20.00% | -50.00% | -- |
| Normalized Basic EPS | -25.00% | -100.00% | -25.00% | -50.00% | -- |
| EPS Diluted | -75.00% | -166.67% | -20.00% | -50.00% | -- |
| Normalized Diluted EPS | -25.00% | -100.00% | -25.00% | -50.00% | -- |
| Average Basic Shares Outstanding | 13.23% | 6.32% | 0.18% | 0.11% | -0.01% |
| Average Diluted Shares Outstanding | 13.23% | 6.32% | 0.18% | 0.11% | -0.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |